YOLFTbeta
Universal Vision Biotechnology Co Ltd

Universal Vision Biotechnology Co Ltd

3218 · TWO · Healthcare / Medical Care Facilities

127.00TWD+1.50 (+1.20%)

Price History

Full chart

Market Stats

Previous Close125.50
Open126.00
Day Range126.00 – 128.00
52-Week Range122.00 – 151.99
Volume109.08K
Market Cap11.31B
P/E (TTM)9.93
Forward P/E40.49
EPS13.45
Dividend Yield5.81%
Beta0.39
50-Day Avg136.55
200-Day Avg137.43

About

Universal Vision Biotechnology Co., Ltd., a biotech company, provides vision care services in Taiwan and China. The company offers various glasses and lenses for vision correction, contact lens solutions, and related eye care products; equipment rental and technical services for laser vision correction instruments; and technology and services for cataract and dry eye examination and treatment instruments. It also trades in medical and pharmaceutical consumables, including ophthalmic drugs, medical supplies, and consumables; and provides administrative and other professional logistics support services for cooperative clinics and eye centers, as well as brand licensing and consulting services. The company offers its products through its self-operated eyeglasses stores. Universal Vision Biotechnology Co., Ltd. was founded in 1992 and is based in Taipei, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryMedical Care Facilities
  • CEOMr. Zhenghong Lu
  • Employees0
  • HeadquartersBuilding G, Taipei, Taiwan, 115, Taiwan
  • Websitehttps://www.uvb.com.tw

Leadership

  • Mr. Zhenghong LuGM & Manager
  • Mr. Pi-Jung LinFounder, President, CTO & Representative Director
  • Yujiao SunDirector of Finance & Accounting and Accounting Supervisor
  • Mr. Yu-chi ChanDirector of Human Resources & Administration Division
  • Mr. Chien-Hsiang YuDirector of Marketing Division
  • Ms. Shu-Hsin LinChief Auditor of Audit Office

Financials

Income Statement

Currency: TWD2003-12-312004-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue186.81M317.76M336.05M396.94M546.23M522.82M691.60M831.53M767.28M853.78M988.44M1.01B1.07B1.08B1.19B1.42B2.05B2.63B3.49B4.08B4.23B4.20B
Growth (%)-+70.10%+5.76%+18.12%+37.61%-4.29%+32.28%+20.23%-7.73%+11.27%+15.77%+2.61%+5.79%+0.88%+10.39%+18.75%+44.69%+28.18%+32.76%+16.83%+3.58%-0.57%
Cost of Revenue62.99M112.42M143.72M156.30M219.97M197.30M269.85M330.49M350.38M313.70M345.54M448.64M481.97M495.42M547.42M601.91M785.99M995.36M1.35B1.63B1.70B1.72B
Gross Profit-----------565.60M591.01M587.01M647.51M817.07M1.27B1.64B2.14B2.45B2.53B2.48B
Gross Margin-----------55.77%55.08%54.23%54.19%57.58%61.72%62.18%61.24%59.98%59.91%59.05%
Operating Expense-----------473.43M477.32M458.04M507.73M570.02M654.07M859.86M1.03B1.11B1.13B1.11B
Operating Income36.60M98.26M85.25M72.82M--1.35M39.16M-89.75M98.08M92.17M113.68M128.96M139.78M247.04M613.08M776.59M1.11B1.34B1.40B1.38B
Operating Margin19.59%30.92%25.37%18.34%--0.20%4.71%-10.51%9.92%9.09%10.60%11.91%11.70%17.41%29.86%29.51%31.86%32.79%33.12%32.76%
EBITDA-------------246.36M296.34M372.70M877.04M1.10B1.49B1.78B1.86B1.91B
EBITDA Margin-------------22.76%24.80%26.27%42.72%41.65%42.52%43.72%44.00%45.53%
Net Income24.60M73.22M67.41M61.01M---27.98M-86.48M101.57M81.07M91.80M120.09M161.48M238.00M483.21M595.43M850.53M1.05B1.06B1.04B
Net Income Margin13.17%23.04%20.06%15.37%---3.37%-10.13%10.28%7.99%8.56%11.09%13.51%16.77%23.54%22.62%24.34%25.60%25.18%24.80%
R&D--1.33M834.00K------------------
R&D as % of Total Revenue--0.40%0.21%------------------
Interest Expense000000000000002.41M12.19M10.94M13.16M13.56M15.83M20.95M24.85M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.20%0.86%0.53%0.50%0.39%0.39%0.50%0.59%

Balance Sheet

Currency: TWD2003-12-312004-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets307.60M383.68M599.41M704.59M1.09B1.12B1.01B1.38B1.26B1.37B1.80B1.89B1.74B2.00B2.10B2.65B3.17B3.75B4.51B5.13B5.76B6.09B
Total Liabilities72.21M77.81M52.51M102.96M550.78M436.73M347.16M244.78M238.35M266.86M662.01M740.12M582.88M421.59M487.91M951.83M1.13B1.42B1.68B1.79B2.01B1.93B
Total Equity235.39M305.87M546.91M601.63M539.22M681.29M663.76M1.14B1.02B1.10B1.14B1.15B1.16B1.41B1.48B1.59B1.91B2.19B2.66B3.18B3.62B4.02B
Cash48.99M63.20M221.70M156.64M511.93M506.13M173.45M450.57M313.04M75.58M290.99M434.50M255.82M614.11M466.35M372.13M616.00M534.19M703.02M1.06B506.85M779.24M
Total Debt---------------472.52M614.14M767.53M783.65M778.26M--
Net Debt---------------100.39M-1.86M233.34M80.63M-284.28M--

Cash Flow

Currency: TWD2003-12-312004-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow55.18M123.14M94.66M-92.94M-84.19M77.91M-183.66M221.81M183.54M255.13M236.48M273.07M419.18M827.08M911.77M1.27B1.55B1.67B1.67B
Investing Cash Flow------------110.61M-293.03M-70.86M-382.01M-223.38M-419.20M-379.81M-564.65M---
Financing Cash Flow--105.92M24.11M380.96M92.05M-254.30M-24.00K254.51M-46.90M-141.08M193.65M-38.41M-282.74M-164.62M-612.33M-539.83M-710.65M--
Capital Expenditure70.03M72.78M32.05M70.57M110.48M56.39M307.25M55.63M88.92M86.80M193.25M281.59M173.88M134.71M204.79M235.19M298.50M328.70M492.83M474.28M437.09M563.82M
Free Cash Flow-------------100.88M66.67M184.00M528.58M583.07M775.34M1.08B1.23B1.10B
Dividends Paid90.00M2.40M31.40M3.47M40.16M---21.96M-66.12M69.43M72.73M87.54M91.35M95.15M152.25M319.72M380.62M479.57M593.07M635.44M
FCF to OCF-------------42.66%24.42%43.89%63.91%63.95%61.14%69.47%73.86%66.17%
Dividend Paid to FCF-------------86.77%137.01%51.71%28.80%54.83%49.09%44.43%48.02%57.63%

Earnings

Report DateOct 30, 2008Apr 22, 2009May 14, 2014Aug 12, 2014Nov 12, 2014Mar 24, 2020May 14, 2020Aug 12, 2020Nov 12, 2020Mar 24, 2021May 11, 2021Aug 10, 2021Nov 10, 2021Mar 29, 2022May 11, 2022Aug 10, 2022Nov 10, 2022Mar 27, 2023May 11, 2023Aug 9, 2023Nov 13, 2023Mar 13, 2024May 9, 2024Aug 12, 2024Nov 13, 2024Mar 12, 2025May 13, 2025Aug 13, 2025Nov 13, 2025Mar 5, 2026May 11, 2026Aug 12, 2026
EPS Estimate0.090.250.470.280.570.750.921.231.781.781.761.902.202.022.342.172.652.793.092.823.393.313.193.183.433.093.553.333.533.423.703.04
EPS Actual0.25-0.940.370.280.380.861.051.361.791.591.761.501.582.172.672.212.433.053.133.073.143.013.583.282.872.804.270.504.043.483.002.67
Surprise177.78%-476.00%-21.28%0.00%-33.33%14.67%14.13%10.57%0.56%-10.67%0.00%-21.05%-28.18%7.43%14.10%1.84%-8.30%9.32%1.29%8.87%-7.37%-9.06%12.23%3.14%-16.33%-9.31%20.28%-84.98%14.45%1.75%-18.92%-12.17%
Timing-After-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-market

Key Statistics & Ratios

Market Cap11.31B
Enterprise Value11.79B
Trailing P/E9.93
Forward P/E40.49
Price / Sales2.65
Price / Book2.92
EPS13.45
Book Value45.72
Revenue (TTM)4.27B
Gross Profit (TTM)2.49B
EBITDA1.70B
Profit Margin26.78%
Operating Margin30.89%
Return on Equity31.24%
Return on Assets13.81%
Shares Outstanding84.72M
Shares Float43.16M
Beta0.39
Dividend Yield5.81%
Dividend Rate7.75
Payout Ratio58.76%

Dividends

20261×
7.75Mar 26, 2026
20251×
7.50Mar 26, 2025
20241×
7.00Apr 18, 2024
20231×
6.00Aug 25, 2023
20221×
4.49Apr 21, 2022
20211×
3.77Apr 15, 2021
20201×
1.80Apr 15, 2020
20191×
1.12Jul 4, 2019
20181×
1.08Jul 16, 2018
20171×
0.45Jul 17, 2017
20161×
0.97Jul 19, 2016
20151×
0.92Jul 16, 2015
20141×
0.88Jul 14, 2014
20121×
0.29Sep 14, 2012
20081×
0.82Jul 25, 2008

Stock Splits

  • Aug 25, 20231060:1000
  • Aug 26, 20221050:1000